Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
View all episodes
By American Academy of Neurology
4.8
132132 ratings
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
More shows like Neurology Minute
View all
NEJM This Week
319 Listeners
JAMA Clinical Reviews
506 Listeners
Neurology® Podcast
298 Listeners
Practical Neurology Podcast
50 Listeners
Mayo Clinic Talks
299 Listeners
The Curbsiders Internal Medicine Podcast
3,360 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,152 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
373 Listeners
Neurology Exam Prep Podcast
188 Listeners
Continuum Audio
84 Listeners